What We’re All About

Our Mission

We are fiercely devoted to the fight against ototoxicity in cancer patients who receive cisplatin-based chemotherapy. Our purpose is to help protect the futures of cancer survivors by preventing hearing loss, so life after cancer can be lived to the fullest.

Our Passion

All age groups are vulnerable to the ototoxic effects of cisplatin-based chemotherapy. The impact of ototoxicity may be permanent, severe, and profound—with the potential to significantly impact cognitive performance, the development of social and language skills, career potential & even the ability to live independently.¹

With cancer rates rising, especially among adolescent and young adult populations², we believe the future of oncological care needs to focus on both survival and survivorship. Through education and collaboration with the oncology community, Fennec is working to ensure that ototoxicity prevention becomes part of the treatment plan.

Our Name

We proudly take our name from the fennec fox, a distinctively large-eared canine that is the smallest of all fox species. Fennec foxes roam the sandy Sahara and greater North African region. Their characteristic ears serve a dual purpose: they are sensitive enough to hear prey underground and also help dissipate the hot desert heat.

Patients undergoing chemotherapy are going through an extraordinarily challenging time, and the loss of hearing only compounds the difficulty. Fennec Pharma, named after that resourceful and determined fennec fox, is committed to helping children at risk of hearing loss due to ototoxicity.

Reference:

1. Landier W. Ototoxicity and cancer therapy. Cancer. 2016;122(11):1647-1658.
2. André F, et al. The rising tides of cancers among young adults. ESMO Open. 2025 Sep;10(9):105553.